Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings

---

Autoria(s): Athan, Eugene; O'Brien, Daniel P.; Legood, Rosa

Data(s)	31/07/2010
Identificador	http://hdl.handle.net/10536/DRO/DU:30050891
Idioma(s)	eng
Publicador	Lippincott Williams & Wilkins
Relação	http://dro.deakin.edu.au/eserv/DU:30050891/athan-costeffectiveness-2010.pdf http://doi.org/10.1097/QAD.0b013e32833b25ed
Palavras-Chave	#AIDS #quality of life #low-cost CD4 T-cell count #HIV #cost-effectiveness
Tipo	Journal Article